Zhicun Sun

Title: Zhicun Sun: Innovator in Pharmaceutical Chemistry

Introduction

Zhicun Sun is a notable inventor based in Tianjin, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the preparation of various chemical compounds. With a total of 3 patents to his name, his work has implications for both research and industrial applications.

Latest Patents

One of Zhicun Sun's latest patents is the "Preparation method of dexmedetomidine intermediate." This invention discloses a method for synthesizing 2,3-dimethyl phenyl-1-trityl-imidazole-4-ketone. The process utilizes imidazole-4-ethyl formate as a raw material and involves several steps, including amino protection and a Grignard reaction, ultimately yielding the target product. This method is noted for its convenience and suitability for industrial production.

Another significant patent is the "Method for preparing temsirolimus." This method involves protecting 2,2-dimethylol propionic acid with a substituted aromatic aldehyde to produce an intermediate. Subsequent reactions lead to the final product, temsirolimus, showcasing Zhicun Sun's expertise in complex chemical synthesis.

Career Highlights

Zhicun Sun has worked with several companies, including Tianjin Weijie Technology Co., Ltd. and Tianjin Weijie Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to apply his innovative ideas in practical settings, contributing to advancements in pharmaceutical development.

Collaborations

Zhicun Sun has collaborated with notable colleagues such as Honghai Song and Long Tang. These partnerships have likely facilitated the exchange of ideas and expertise, further enhancing the impact of his work in the field.

Conclusion

Zhicun Sun is a distinguished inventor whose contributions to pharmaceutical chemistry are noteworthy. His innovative methods for synthesizing important chemical compounds demonstrate his commitment to advancing the field. His work continues to influence both research and industrial practices in pharmaceuticals.